Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novo Nordisk Pharma GmbH
Woman and Man Max 99 years
Novo Nordisk Pharma GmbH
Update Il y a 5 ans
A 52 week, Open Labelled, Randomised multi-centre 2 Arm Parallel Group Trial comparing Efficacy and Safety of Insulin Aspart, given in a Fixed Dose Regimen or in a Flexible Regimen, with or without Insulin Detemir in Subjects with Type 2 Diabetes
The primary objective of the trial is to compare the glycaemic control, measured as HbA1c after 52 weeks of treatment, in patients with type 2 diabetes treated with a supplementary insulin therapy (SI...
Country
None
organs
None
Specialty
None
Closed trial
More information